Cargando…

Blood pressure variability in Parkinson's Disease patients – Case control study

INTRODUCTION: The cardiovascular risk of Parkinson’s Disease (PD) patients is uncertain. Blood pressure variability (BPV) has been associated with cardiovascular and mortality outcomes. We aimed to evaluate blood pressure variability, as a marker of cardiovascular risk, in patients with PD and match...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves, Mariana, Caldeira, Daniel, Ferreira, Joaquim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995452/
https://www.ncbi.nlm.nih.gov/pubmed/36908283
http://dx.doi.org/10.1016/j.prdoa.2023.100191
_version_ 1784902827633541120
author Alves, Mariana
Caldeira, Daniel
Ferreira, Joaquim J.
author_facet Alves, Mariana
Caldeira, Daniel
Ferreira, Joaquim J.
author_sort Alves, Mariana
collection PubMed
description INTRODUCTION: The cardiovascular risk of Parkinson’s Disease (PD) patients is uncertain. Blood pressure variability (BPV) has been associated with cardiovascular and mortality outcomes. We aimed to evaluate blood pressure variability, as a marker of cardiovascular risk, in patients with PD and matched community controls. METHODS: Cross-sectional case-control study was performed. All subjects included in the analysis were clinically evaluated and performed a 24 h ambulatory blood pressure monitoring. BPV was assessed using standard deviations (SDs) of the systolic blood pressure (SBP) and diastolic blood pressure (DBP) for each period – 24 h, daytime, and night-time. RESULTS: The study included 204 participants, 102 in each group. Mean age 66 years old and 59% man. Most PD patients presented mild symptoms (mean Hoehn&Yahr 2.04). Daytime BPV was significantly higher in PD patients (SD SBP 14.1 mmHg vs 12.96 mmHg and SD DBP 9.39 mmHg vs 8.29 mmHg), but 24 h and night-time BPV were non-significantly increased. PD patients present non-significant higher night-time SBP (114 mmHg vs 110 mmHg) as well as higher frequency of non-dippers or reverse dippers BP profiles (51% vs 36%). CONCLUSION: Our exploratory study suggests that PD patients may present a higher blood pressure variability, which may translate in an increased cardiovascular risk. However, further studies are needed to confirm this hypothesis and causality.
format Online
Article
Text
id pubmed-9995452
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99954522023-03-10 Blood pressure variability in Parkinson's Disease patients – Case control study Alves, Mariana Caldeira, Daniel Ferreira, Joaquim J. Clin Park Relat Disord Short Communications INTRODUCTION: The cardiovascular risk of Parkinson’s Disease (PD) patients is uncertain. Blood pressure variability (BPV) has been associated with cardiovascular and mortality outcomes. We aimed to evaluate blood pressure variability, as a marker of cardiovascular risk, in patients with PD and matched community controls. METHODS: Cross-sectional case-control study was performed. All subjects included in the analysis were clinically evaluated and performed a 24 h ambulatory blood pressure monitoring. BPV was assessed using standard deviations (SDs) of the systolic blood pressure (SBP) and diastolic blood pressure (DBP) for each period – 24 h, daytime, and night-time. RESULTS: The study included 204 participants, 102 in each group. Mean age 66 years old and 59% man. Most PD patients presented mild symptoms (mean Hoehn&Yahr 2.04). Daytime BPV was significantly higher in PD patients (SD SBP 14.1 mmHg vs 12.96 mmHg and SD DBP 9.39 mmHg vs 8.29 mmHg), but 24 h and night-time BPV were non-significantly increased. PD patients present non-significant higher night-time SBP (114 mmHg vs 110 mmHg) as well as higher frequency of non-dippers or reverse dippers BP profiles (51% vs 36%). CONCLUSION: Our exploratory study suggests that PD patients may present a higher blood pressure variability, which may translate in an increased cardiovascular risk. However, further studies are needed to confirm this hypothesis and causality. Elsevier 2023-03-01 /pmc/articles/PMC9995452/ /pubmed/36908283 http://dx.doi.org/10.1016/j.prdoa.2023.100191 Text en © 2023 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Short Communications
Alves, Mariana
Caldeira, Daniel
Ferreira, Joaquim J.
Blood pressure variability in Parkinson's Disease patients – Case control study
title Blood pressure variability in Parkinson's Disease patients – Case control study
title_full Blood pressure variability in Parkinson's Disease patients – Case control study
title_fullStr Blood pressure variability in Parkinson's Disease patients – Case control study
title_full_unstemmed Blood pressure variability in Parkinson's Disease patients – Case control study
title_short Blood pressure variability in Parkinson's Disease patients – Case control study
title_sort blood pressure variability in parkinson's disease patients – case control study
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995452/
https://www.ncbi.nlm.nih.gov/pubmed/36908283
http://dx.doi.org/10.1016/j.prdoa.2023.100191
work_keys_str_mv AT alvesmariana bloodpressurevariabilityinparkinsonsdiseasepatientscasecontrolstudy
AT caldeiradaniel bloodpressurevariabilityinparkinsonsdiseasepatientscasecontrolstudy
AT ferreirajoaquimj bloodpressurevariabilityinparkinsonsdiseasepatientscasecontrolstudy